Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 3Congenital Abnormalities 3Leukemia 2Carcinoma, Hepatocellular 2Myeloproliferative Disorders 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Breast Neoplasms 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cytarabine 58Etoposide 24Daunorubicin 22Filgrastim 18Idarubicin 16Mitoxantrone 13Busulfan 13tipifarnib 11fludarabine phosphate 10Gemtuzumab 10Cyclophosphamide 10Peripheral Blood Stem Cell Transplantation 9Flow Cytometry 9sargramostim 8Clofarabine 8Methotrexate 7Gene Expression Profiling 7Cyclosporine 7Topotecan 6Azacitidine 6valspodar 5alvocidib 5Granulocyte Colony-Stimulating Factor 5Antilymphocyte Serum 5aldesleukin 4Radiotherapy 4Observation 4Bortezomib 4Arsenic Trioxide 4Vorinostat 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Monocytic, Acute × Pravastatin × Clear all
NCT01831232 2017-11-17

Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

Fred Hutchinson Cancer Center

Phase NA Completed
24 enrolled 11 charts
Classical hematologyMyeloidOther hematologic neoplasm

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡